Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats
Published on: June 14, 2024
Oxygen Nanocarriers for Improving Cardioplegic Solution Performance: Physico-Chemical Characterization.
Maria Tannous1,2,3, Gjylije Hoti1, Francesco Trotta1
1Department of Chemistry, University of Turin, 10125 Turin, Italy.
Oxygen-releasing nanosponges enhance cardioplegic solutions for organ transplantation. Cyclic nigerosyl-nigerose-based nanosponges show superior oxygen delivery, extending heart preservation times.
Area of Science:
- Biomaterials Science
- Cardiovascular Research
- Nanotechnology
Background:
- Oxygenated cardioplegic solutions (CS) improve myocardial protection during cardiac arrest but offer limited duration.
- Nanocarriers are explored for sustained oxygen delivery to overcome limitations in current therapeutic strategies.
- Organ transplantation requires effective methods for preserving organs during ischemic periods.
Purpose of the Study:
- To develop and evaluate nanocarriers for prolonged oxygen release in cardioplegic solutions.
- To enhance myocardial protection and organ preservation times in transplantation.
- To investigate the oxygen storage and release capabilities of different nanocarrier formulations.
Main Methods:
- Preparation of nanocarrier formulations including native α-cyclodextrin (αCD), αCD-based nanosponges (αCD-NSs), native cyclic nigerosyl-nigerose (CNN), and CNN-based nanosponges (CNN-NSs).
- Assessment of oxygen release kinetics and concentration from nanocarriers in a National Institutes of Health (NIH) CS at 37 °C.
- Physicochemical characterization of nanocarriers for oxygen storage capacity and release profiles at low temperatures.
Main Results:
- Nanosponges (NSs) demonstrated higher oxygen release over 24 hours compared to native αCD and CNN.
- CNN-NSs achieved the highest oxygen concentration (8.57 mg/L) in NIH CS at 37 °C over 12 hours.
- NSs exhibited superior oxygen retention (1.30 g/L) compared to other formulations, indicating prolonged release potential.
Conclusions:
- Oxygenated nanocarriers, particularly CNN-NSs, offer a promising approach for sustained oxygen delivery in cardioplegic solutions.
- These nanocarriers can significantly extend the duration of myocardial protection and organ viability during hypothermic storage.
- The developed nanocarrier formulations are suitable for preserving organs during explant and transport procedures in transplantation.
More Related Videos
06:57Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
Published on: August 11, 2018
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
Related Concept Videos
Oxygen Transport in the Blood
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...